Takeda's office in Czech Republic: krtova Prague Vinohrady Czech Republic
Business Address: Škrétova 490/12 120 00 Prague 2-Vinohrady Czech Republic
Phone: +420 731 620 895; +420 234 722 722
E-mail: info-cz@takeda.com
| Native name | 武田薬品工業株式会社 |
|---|---|
| Romanized name | Takeda Yakuhin Kōgyō kabushiki gaisha |
| Formerly | Chobei Takeda & Co., Ltd. (1925-1943) Takeda Pharmaceutical Industries, Ltd. (English name only 1943-1961) Takeda Chemical Industries, Ltd. (English name only 1961-2004) |
| Type | Public KK |
| Traded as | |
| Industry | Pharmaceuticals |
| Founded | Doshomachi, Osaka, Japan (June 12, 1781 (1781-06-12)) |
| Founder | Chobei Takeda I |
| Headquarters | Nihonbashi, Chuo, Tokyo, Japan |
| Key people | Yasuchika Hasegawa (Chairman of the Board) Christophe Weber (President & CEO) |
| Revenue | |
| Operating income | |
| Net income | |
| Total assets | |
| Total equity | |
| Owner | Nippon Life (2.24%),
BNY Mellon(5.39%) JPMorgan Chase(3.50%) State Street Corporation(1.50%) |
| Number of employees | 49,578 (2019)
(18,378) in United States (5,350) in Japan |
| Website | takeda.com (Global website) |
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan. We have presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world. We will deliver highly innovative medicines and transformative care for more people globally.